ADVANCED HEALTH LIMITED - Dealings by directors arising out of Rights Offer

Dealings by directors arising out of Rights Offer

ADVANCED HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2013/059246/06)
(“the Company” or “Advanced Health”)
ISIN Code: ZAE000189049        JSE Code: AVL


DEALINGS BY DIRECTORS ARISING OUT OF RIGHTS OFFER


In compliance with paragraphs 3.63 to 3.74 of the Listings Requirements of the Johannesburg Stock
Exchange (“JSE”), the following information relating to trades in the ordinary shares of the Company
by the directors of the company pursuant to the Rights Offer is disclosed:

Name of director:                           Carl Alfred Grillenberger (CEO)
Name of company:                            Advanced Health Limited
Date of transaction:                        7 August 2017 with regard to primary subscription
Number of securities:                       32 206 987
Class of securities:                        Ordinary shares
Nature of transaction:                      Subscription for shares arising from the Rights Offer
Price per share:                            130 cents per share
Nature of interest:                         Indirect beneficial
Extent of interest:                         Less than 9.10%
Value of transaction:                       R41 869 082.81
Clearance to deal obtained:                 Yes

Name of director:                           Frans van Hoogstraten (Non-Executive)
Name of company:                            Advanced Health Limited
Date of transaction:                        7 August 2017 with regard to primary subscription
Number of securities:                       14 975
Class of securities:                        Ordinary shares
Nature of transaction:                      Subscription for shares arising from the Rights Offer
Price per share:                            130 cents per share
Nature of interest:                         Indirect beneficial
Extent of interest:                         Less than 0.01%
Value of transaction:                       R19 467.50
Clearance to deal obtained:                 Yes

Name of director:                           Marc Resnik (Managing Director – Presmed Australia)
Name of company:                            Advanced Health Limited
Date of transaction:                        7 August 2017 with regard to primary subscription
Number of securities:                       74 875
Class of securities:                        Ordinary shares
Nature of transaction:                      Subscription for shares arising from the Rights Offer
Price per share:                            130 cents per share
Nature of interest:                         Indirect beneficial
Extent of interest:                         Less than 0.03%
Value of transaction:                       R97 337.50

Clearance to deal obtained:                 Yes
Name of director:                           Cor van Zyl (Non-Executive)
Name of company:                            Advanced Health Limited
Date of transaction:                        7 August 2017 with regard to primary subscription and
                                            10 August 2017 with regard to excess allocations
Number of securities:                       308 592, comprising 209 650 in terms of the primary
                                            subscription and 98 942 in terms of the excess
                                            allocation
Class of securities:                        Ordinary shares
Nature of transaction:                      Subscription for shares arising from the Rights Offer
Price per share:                            130 cents per share
Nature of interest:                         Indirect and direct beneficial
Extent of interest:                         Less than 0.05%
Value of transaction:                       R401 169.60
Clearance to deal obtained:                 Yes

Name of director:                  Johan Oelofse (Non-Executive)
Name of company:                   Advanced Health Limited
Date of transaction:               7 August 2017 with regard to primary subscription
Number of securities:              119 800
Class of securities:               Ordinary shares
Nature of transaction:             Subscription for shares arising from the Rights Offer
Price per share:                   130 cents per share
Nature of interest:                Indirect beneficial
Extent of interest:                Less than 0.04%
Value of transaction:              R155 740
Clearance to deal obtained:        Yes

Name of director:                  Cobus Visser (Alternate)
Name of company:                   Advanced Health Limited
Date of transaction:               7 August 2017 with regard to primary subscription
Number of securities:              4 617 108
Class of securities:               Ordinary shares
Nature of transaction:             Subscription for shares arising from the Rights Offer
Price per share:                   130 cents per share
Nature of interest:                Indirect beneficial
Extent of interest:                Less than 0.52%
Value of transaction:              R6 002 240.40
Clearance to deal obtained:        Yes

Johannesburg
11 August 2017

Designated Advisor
Grindrod Bank Limited

Date: 11/08/2017 12:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.